Value of monoclonal antibody OKT3 in solid organ transplantation: a meta-analysis.
Carrier
M
M
Department of Surgery, Montreal Heart Institute, Quebec, Canada.
Jenicek
M
M
Pelletier
L C
LC
D000961:Antilymphocyte Serum / Q000008:administration & dosage; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology / Q000401:mortality / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000401:mortality / Q000517:prevention & control*; D011446:Prospective Studies; D015996:Survival Rate
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3